By John Arthur 
Over 60,000 Roundup lawsuits remain active as Bayer pushes a proposed $7.25 billion settlement to address claims that the popular weedkiller causes non-Hodgkin lymphoma. If you or a loved one used Roundup for gardening, farming, or landscaping and later received a cancer diagnosis, you are not alone. Many face mounting medical bills, lost wages, and uncertainty about the future.
This guide explains the Roundup lawsuit developments, eligibility for the proposed settlement, potential payouts, and steps to protect your rights. Understanding your options can help you secure fair compensation while navigating a complex legal process. Bayer maintains that glyphosate, the active ingredient in Roundup, does not cause cancer. Yet juries have awarded massive verdicts in favor of plaintiffs, and scientific bodies like the International Agency for Research on Cancer have classified glyphosate as a probable human carcinogen.
The History of Roundup and Glyphosate Concerns
Roundup hit the market in the 1970s and quickly became one of the most widely used herbicides worldwide. Homeowners, farmers, and landscapers relied on it for effective weed control. The key ingredient, glyphosate, disrupts plant growth but has sparked debate over its effects on human health.
In 2015, the World Health Organization’s International Agency for Research on Cancer (IARC) determined that glyphosate is “probably carcinogenic to humans,” with strong links to non-Hodgkin lymphoma (NHL). This classification fueled thousands of lawsuits against Monsanto (acquired by Bayer in 2018). Plaintiffs allege the company knew about risks but failed to provide adequate warnings.
Real-world stories illustrate the impact. Consider a longtime farmer who sprayed Roundup daily for decades before developing aggressive NHL in his 50s. Or a homeowner who used it regularly in the backyard and faced a life-altering diagnosis years later. These cases highlight how everyday exposure can lead to serious consequences.
Understanding the Roundup Lawsuits
The core allegation in Roundup cancer lawsuits is that prolonged exposure to glyphosate-based products increases the risk of non-Hodgkin lymphoma and related blood cancers. Symptoms of NHL often include swollen lymph nodes, fatigue, unexplained weight loss, and recurrent infections.
Lawsuits claim Bayer (Monsanto) knew or should have known about these risks but prioritized profits over safety. By June 2026, Bayer has already resolved roughly 100,000 claims for about $11 billion in prior settlements. Yet more than 60,000 cases persist, with new filings continuing as cancer diagnoses emerge.
Key cancers associated with claims include:
- Non-Hodgkin lymphoma (various subtypes like diffuse large B-cell)
- Chronic lymphocytic leukemia
- Other related lymphomas
Courts have seen mixed results. Plaintiffs have secured notable verdicts, including multimillion-dollar awards with significant punitive damages. Bayer has won some trials but continues facing pressure from ongoing litigation.
Bayer’s Proposed $7.25 Billion Settlement Explained
In February 2026, Bayer announced a proposed nationwide class settlement totaling up to $7.25 billion to resolve current and future Roundup claims. The funds would be paid out over up to 21 years in declining annual installments, providing Bayer financial predictability while offering a claims program for victims.
A Missouri state court granted preliminary approval in March 2026. As of mid-June 2026, the settlement was remanded back to state court after federal proceedings, where it continues moving forward despite objections. Some plaintiffs argue the deal may undervalue claims or favor certain parties, and appeals are expected.
Important note: Bayer does not admit liability in the settlement. Participation is typically optional, and individuals can opt out to pursue individual claims.
Estimated Payouts and Tiers
Individual payouts under the proposed settlement are estimated between $6,000 and $165,000. Higher amounts target:
- Professional users (e.g., farmers, landscapers) with heavy exposure
- Those diagnosed at younger ages (under 60)
- Aggressive forms of cancer
Factors influencing amounts include duration and intensity of exposure, age at diagnosis, cancer severity, and medical documentation. The tiered structure aims to prioritize severe cases while covering future claimants diagnosed within a set period after approval.
These figures represent averages and are not guaranteed. Actual compensation depends on final court approval, claim validation, and available funds.
Who Qualifies for the Roundup Settlement or Lawsuit?
Eligibility generally requires:
- Significant exposure to Roundup or glyphosate products (often for multiple years or hundreds of hours)
- A diagnosis of non-Hodgkin lymphoma or a related cancer
- Diagnosis occurring after exposure began, within applicable statutes of limitations
Proof typically includes medical records, exposure history (purchase receipts, work logs, witness statements), and expert testimony linking exposure to the illness.
Future claimants (those diagnosed later) may also qualify under the proposed long-term program. U.S. residents or those exposed in the U.S. before February 17, 2026, are primary targets.
Consult an experienced attorney for a free case evaluation. Time limits vary by state, so acting promptly preserves your rights.
How to File a Roundup Claim: Step-by-Step Guide
- Gather Evidence: Collect medical records confirming your NHL diagnosis, proof of Roundup use (photos, receipts, employment records), and any symptom timeline.
- Contact a Lawyer: Seek firms specializing in mass torts or product liability. Many offer contingency fees (no upfront costs).
- Evaluate Options: Decide between joining the class settlement (if eligible) or pursuing an individual lawsuit for potentially higher compensation.
- File the Claim: Your attorney submits necessary documentation. For the settlement, this involves registering through the claims program and providing required proofs.
- Monitor Deadlines: Key opt-out and objection deadlines apply. Stay informed through court notices or your legal team.
Common pitfalls include missing statutes of limitations or incomplete documentation. An attorney helps avoid these issues.
For official guidance on related regulatory matters, review resources from the Environmental Protection Agency or state health departments.
Challenges and Criticisms of the Settlement
Some plaintiffs and attorneys have filed objections, claiming the deal may not adequately compensate victims or properly represent class interests. Concerns include the structured payout timeline and potential undervaluation for severe cases. Legal challenges continue, including attempts to move proceedings to federal court.
Despite this, the settlement offers a path to resolution for many without the uncertainty of trials. Juries have shown willingness to award large sums when evidence is strong, but trials carry risks.
Bayer has removed glyphosate from some consumer Roundup formulations in the U.S., but agricultural versions remain in use.
What to Expect Moving Forward
The settlement process involves further court review, potential modifications based on objections, and final approval hearings. A U.S. Supreme Court decision on related preemption issues could also influence future claims.
If approved, the claims program could begin distributing funds relatively soon after finalization. For those opting out, individual lawsuits or multidistrict litigation (MDL) remain options.
Protecting Your Health and Rights
If you suspect Roundup exposure contributed to your cancer, prioritize medical care and legal consultation. Early action maximizes compensation potential for treatment, lost income, pain and suffering, and other damages.
Unique insight: Many victims initially hesitate due to the “it’s just a weedkiller” perception. Yet the volume of evidence and jury verdicts suggest otherwise. Documenting exposure early strengthens any claim.
Conclusion
The Roundup lawsuit landscape offers hope for accountability through Bayer’s proposed $7.25 billion settlement and continued individual actions. While details evolve, eligible victims may recover significant compensation for cancer linked to glyphosate exposure.
Key takeaways include understanding eligibility, gathering strong evidence, and consulting qualified legal counsel promptly. Do not delay. Contact a Roundup attorney today for a confidential evaluation of your case. They can guide you toward the best path, whether through the settlement or standalone litigation.